Advertisement
Advertisement
Trending on Urology Times
1
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
2
Managing Immune-Related Adverse Events With Durvalumab Plus BCG in NMIBC
3
The Expert APProach: Advancing APP Leadership and Expertise in Urology, With Susanne Quallich, PhD, ANP-BC, NP-C
4
POTOMAC Subgroup Data: Cystectomy Risk and Rare Adverse Events in NMIBC
5